Home/Filings/4/0000899243-18-022378
4//SEC Filing

LONGENECKER JOHN P PHD 4

Accession 0000899243-18-022378

CIK 0001420565other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 7:38 PM ET

Size

5.1 KB

Accession

0000899243-18-022378

Insider Transaction Report

Form 4
Period: 2018-08-10
LONGENECKER JOHN P PHD
President and CEO
Transactions
  • Purchase

    Common Stock

    2018-08-10$2.45/sh+10,000$24,50010,000 total
Footnotes (1)
  • [F1]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40 to $2.48, inclusive. The reporting person undertakes to provide to Aileron Therapeutics, Inc., any security holder of Aileron Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001288231

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:38 PM ET
Size
5.1 KB